U.S. Patent No. 12,329,781 relates to Minovia’s proprietary mitochondrial augmentation technology for the treatment of renal diseases, including renal tubulopathy, kidney insufficiency, and chronic ...

January is the perfect time to reset and nourish your body. Naturya’s superfood products make healthy living simple with ...

Aim for a balanced diet with a variety of foods in order to get enough vitamin E and vitamin K. While sun protection is good, ...

Minovia Therapeutics Ltd. ("Minovia" or the "Company"), a clinical-stage biotechnology company developing novel therapies to treat mitochondrial diseases ...

Medical science can typically provide a clear explanation of the intricacies of the human body. However, there are times when ...

Watching from the sidelines was Dr. Karen Douek, a retired nephrologist who, at the time, was a stranger to Alcazar. Douek ...

Biomarkers associated with cognitive impairment differ between men and women with chronic kidney disease, according to data ...

Until about five years ago, scientists believed the pregnancy hormone, human chorionic gonadotropin (hCG), was the culprit.

Not intended for US and UK audiences BI 765423 has been developed to target IL-11, a key driver of fibrosis New study will investigate potential of BI 765423 to improve lung function for patients ...

This condition, called hyperemesis gravidarum, can last the whole pregnancy and be dangerous for both the woman and the fetus ...